DUSP16 and cancer: Subsequent investigations revealed that the upregulation of DUSP16 in neoplastic cells conferred augmented resistance to apoptotic cell death following chemotherapy, whereas the downregulation of DUSP16 enhanced the sensitivity of cancer cells toward treatment [26].